Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB26FNMMZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,973
Award facts
- Contract value 100% obligated
- $83,973.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for ALYFTREK 10-50-125 mg tablets (14-count packages) with a ceiling value of $83,973.24. This firm fixed-price delivery order, awarded on October 23, 2025, with an ultimate completion date of October 24, 2025, carries no set-aside designation, indicating the awardee competed in the unrestricted federal marketplace. DMS Pharmaceutical Group was selected as the prime contractor with no identified subcontractors involved in the award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals including branded and generic prescription drugs, biologics, and medical consumables to support military medical facilities globally. This particular order reflects DMS Pharmaceutical Group's established role as a critical pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FNMMZ?
SPE2DB26FNMMZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FNMMZ worth?
The government has obligated $83,973 on SPE2DB26FNMMZ.
Is contract SPE2DB26FNMMZ an order under another contract?
Yes. SPE2DB26FNMMZ is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMMZ competed?
The extent of competition for SPE2DB26FNMMZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award